Daratumumab With DCEP for Multiple Myeloma With Plasmacytoma

Conditions:   Multiple Myeloma in Relapse;   Plasmacytoma;   Daratumumab Intervention:   Drug: Drug Combinations Sponsor:   Seoul National University Hospital Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials